Assignee
ZAFGEN INC
US·35 granted patents·32 pending applications·173 citations·filing 2012–2019
Top patents by PatentIndex Score
67 records- 0198US8367721B2Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2012·Granted Feb 5, 2013·57 cites·2 claims
- 0296US9682965B2Fumagillol heterocyclic compounds and methods of making and using sameZAFGEN INC·Filed 2016·Granted Jun 20, 2017·8 cites·9 claims
- 0394US9000035B2Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillolZAFGEN INC·Filed 2013·Granted Apr 7, 2015·18 cites·12 claims
- 0494US8980946B2Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillolZAFGEN INC·Filed 2013·Granted Mar 17, 2015·19 cites·6 claims
- 0594US8349891B2Crystalline solids of a MetAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2012·Granted Jan 8, 2013·28 cites·21 claims
- 0689US8735447B2Crystalline solids of a MetAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2012·Granted May 27, 2014·5 cites·17 claims
- 0787US9573918B2Fumigillol compounds and methods of making and using sameZAFGEN INC·Filed 2013·Granted Feb 21, 2017·6 cites·17 claims
- 0886US9649293B2Methods of treating an overweight subjectZAFGEN INC·Filed 2014·Granted May 16, 2017·4 cites·10 claims
- 0985US9597309B2Methods of treating renal disease and other disordersZAFGEN INC·Filed 2014·Granted Mar 21, 2017·2 cites·16 claims
- 1083US9067913B2Fumigillol type compounds and methods of making and using sameZAFGEN INC·Filed 2014·Granted Jun 30, 2015·4 cites·3 claims
- 1181US10023561B2Fumagillol heterocyclic compounds and methods of making and using sameZAFGEN INC·Filed 2017·Granted Jul 17, 2018·1 cites·6 claims
- 1281US9359369B2Tricyclic sulfonamide compounds and methods of making and using sameZAFGEN INC·Filed 2013·Granted Jun 7, 2016·5 cites·26 claims
- 1378US9446016B2Methods of treating age related disordersZAFGEN INC·Filed 2014·Granted Sep 20, 2016·2 cites·10 claims
- 1478US9371312B2Crystalline solids of a MetAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2014·Granted Jun 21, 2016·1 cites·9 claims
- 1577US9895339B2Fumigillol compounds and methods of making and using sameZAFGEN INC·Filed 2017·Granted Feb 20, 2018·1 cites·21 claims
- 1676US9827221B2Crystalline solids of a metAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2016·Granted Nov 28, 2017·1 cites·7 claims
- 1776US9440943B2Tricyclic sulfone compounds and methods of making and using sameZAFGEN INC·Filed 2013·Granted Sep 13, 2016·3 cites·23 claims
- 1875US9839622B2Methods of treating hypothalamic obesityZAFGEN INC·Filed 2013·Granted Dec 12, 2017·2 cites·2 claims
- 1975US9701651B2Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2015·Granted Jul 11, 2017·1 cites·2 claims
- 2074US9617237B2Partially saturated tricyclic compounds and methods of making and using sameZAFGEN INC·Filed 2016·Granted Apr 11, 2017·1 cites·2 claims
- 2173US9944613B2Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using sameZAFGEN INC·Filed 2017·Granted Apr 17, 2018·1 cites·14 claims
- 2273US2019084968A1Fumagillol heterocyclic compounds and methods of making and using sameZAFGEN INC·Filed 2018·Application pending·0 cites
- 2372US10064839B2Methods of treating liver diseasesZAFGEN INC·Filed 2016·Granted Sep 4, 2018·1 cites·10 claims
- 2472US9656979B2Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2015·Granted May 23, 2017·1 cites·7 claims
- 2572US2019224156A1Methods of Treating an Overweight or Obese SubjectZAFGEN INC·Filed 2018·Application pending·0 cites
- 2670US9561209B2Methods of treating liver diseasesZAFGEN INC·Filed 2013·Granted Feb 7, 2017·1 cites·13 claims
- 2770US2015209320A1Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2013·Application pending·0 cites
- 2869US10231946B2Methods of treating ischemic organ damage and other disordersZAFGEN INC·Filed 2017·Granted Mar 19, 2019·0 cites·10 claims
- 2968US2019084969A1Fumagillol heterocyclic compounds and methods of making and using sameZAFGEN INC·Filed 2018·Application pending·0 cites
- 3068US2018064677A1Methods of Treating an Overweight or Obese SubjectZAFGEN INC·Filed 2017·Application pending·0 cites
- 3166US2018016249A1Methods of Treating an Overweight or Obese SubjectZAFGEN INC·Filed 2017·Application pending·0 cites
- 3265US10220015B2Fumigillol compounds and methods of making and using sameZAFGEN INC·Filed 2018·Granted Mar 5, 2019·0 cites·6 claims
- 3364US2015157595A1Methods of treating a subject with benign prostate hyperplasiaZAFGEN INC·Filed 2014·Application pending·0 cites
- 3463US10406134B2Methods of treating an overweight subjectZAFGEN INC·Filed 2017·Granted Sep 10, 2019·0 cites·7 claims
- 3563US2018221328A1Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl FumagillolZAFGEN INC·Filed 2017·Application pending·0 cites
- 3663US2019388380A1Fumagillol type compounds and methods of making and using sameZAFGEN INC·Filed 2019·Application pending·0 cites
- 3762US2018230137A1Fumagillol heterocyclic compounds and methods of making and using sameZAFGEN INC·Filed 2016·Application pending·0 cites
- 3862US2015216835A1Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2014·Application pending·0 cites
- 3962US2017209596A1Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the SameZAFGEN INC·Filed 2016·Application pending·0 cites
- 4060US10259796B2Oxaspiro[2.5]octane derivatives and analogsZAFGEN INC·Filed 2017·Granted Apr 16, 2019·0 cites·9 claims
- 4160US9849106B2Methods of treating impaired wound healingZAFGEN INC·Filed 2017·Granted Dec 26, 2017·0 cites·15 claims
- 4260US2014107171A1Methods of Treating an Overweight or Obese SubjectZAFGEN INC·Filed 2013·Application pending·0 cites
- 4360US2019022051A1Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2018·Application pending·0 cites
- 4459US9925166B2Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2016·Granted Mar 27, 2018·0 cites·3 claims
- 4559US2020003759A1Methods for identifying metap-2 modulatorsZAFGEN INC·Filed 2018·Application pending·0 cites
- 4659US2020030278A1Pharmaceutical compositions of metap-2 inhibitorsZAFGEN INC·Filed 2018·Application pending·0 cites
- 4758US2019092781A1Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using sameZAFGEN INC·Filed 2018·Application pending·0 cites
- 4857US2019175542A1Methods of treating age related disordersZAFGEN INC·Filed 2018·Application pending·0 cites
- 4957US2016243073A1Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl FumagillolZAFGEN INC·Filed 2015·Application pending·0 cites
- 5056US2015209321A1Treatment of obesity using non-daily administration of 6-o-(4-dimethylaminoethoxy) cinnamoyl fumagillolZAFGEN INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ZAFGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →